Cancer chemotherapeutic agents have a low therapeutic index and require a precise and safe prescription. Hematological toxicity is the most common dose limiting side effect of cancer drugs. Therefore, Hemopoietic Stem Cells (HSC) are the most relevant targets for dose determination. Studies of total
In response to Vriesendorp et al. Prediction of normal tissue damage by cancer chemotherapy
β Scribed by John A. Green
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 109 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We studied the relationship between response of breast cancer to docetaxel (DOC) or cylophosphamide + epirubucin (CE) treatment and CYP3A4 mRNA expression in breast tumors. CYP3A4 inactivates DOC but not E, which is a predominant effector in CE treatment. Twenty patients with locally ad
## Abstract The aim of this study was to assess the predictive power of ^99m^TcβMIBI scintigraphy performed in the middle of chemotherapy, for the final tumor response to chemotherapy, and compare it to that of ^201^Tl in malignant bone and soft tissue tumors (MBST). Sixtyβeight patients with MBST